secwatch / observer

Earnings Releases

Quarterly and annual results disclosed under 8-K Item 2.02.

8-K items 2.02 JSON
IHRT iHeartMedia, Inc.

iHeartMedia, Inc. reported the quarter ended March 31, 2026 results: revenue $884 million, net income $1.5 million. Guidance reaffirmed.

“– iHeartMedia, Inc. (Nasdaq: IHRT) today reported financial results for the quarter ended March 31, 2026. Financial Highlights: 1 Q1 2026 Consolidated Results ▪ Q1 Revenue of $884 million, up 9.6% (Excluding Q1 Political Revenue, Q1 Revenue up 9.3%) ▪ GAAP Operating income of $1.5 million, compared to a GAAP Operating loss of $25 million in Q1 2025, improvement of”
HLIT HARMONIC INC.

HARMONIC INC. updated its first quarter ended April 3, 2026 guidance (raised).

“On May 11, 2026, Harmonic Inc. (the “ Company ”) issued a press release regarding its preliminary unaudited financial results for the quarter ended April 3, 2026”
TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc. reported three months ended March 31, 2026 results: net income $ (970,972 ), EPS $ (0.03 ).

“Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunological therapies for dermatologic conditions, today reported financial results for the three months ended March 31, 2026”
HCAT Health Catalyst, Inc.

Health Catalyst, Inc. reported financial results for the quarter ended March 31, 2026.

“On May 11, 2026 , Health Catalyst, Inc. (the "Company") issued a press release relating to its financial results for the quarter ended March 31, 2026 .”
VTSI VirTra, Inc

VirTra, Inc reported first quarter ended March 31, 2026 results: revenue $3.5 million, net income $(1.3) million, EPS $(0.12) per diluted share.

“with better data, and we believe we are well-positioned as funding and procurement conditions continue to normalize.” First Quarter 2026 Financial Results Total revenue was $3.5 million, compared to $7.2 million in the prior year period. The decrease was due to a number of our Q3 and Q4 booking customers being unable to accept delivery in Q1 of 2026.”
SKYX SKYX Platforms Corp.

SKYX Platforms Corp. reported the first quarter ended March 31, 2026 results: revenue $22 million, EPS $0.07 per share.

“(EX-99.1) --- Exhibit 99.1 Earnings Press Release, dated May 11, 2026 SKYX Reports 9 Consecutive Quarters of Growth YoY with 10% Increase and Record Revenues in Q-1 2026 with $22 Million Compared to $20 Million in Q-1 2025 as It Continues to Grow Its Market Penetration SKYX Reports over $32 Million in Cash and Cash Equivalents as of March 31, 2026, Management”
AMPY Amplify Energy Corp.

Amplify Energy Corp. updated its the first quarter of 2026 guidance (reaffirmed).

“On May 11, 2026, Amplify Energy Corp., a Delaware corporation (the “Company”), issued a press release reporting the Company’s financial and operating results for the quarter ended March 31, 2026.”
COOK Traeger, Inc.

Traeger, Inc. reported the three months ended March 31, 2026 results: revenue $94.1 million, net income $2.9 million, EPS $1.08 per diluted share. Guidance raised.

“leader of the wood pellet grill, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Results • Total revenues decreased 34.3% to $94.1 million • Grill revenues decreased 45.4% to $47.4 million • Net income of $2.9 million or $1.08 per diluted share 1 • Adjusted EBITDA of $17.3 million • Operating cash flow of $17.9”
DCGO DocGo Inc.

DocGo Inc. reported the first quarter ended March 31, 2026 results: revenue $75.6 million, net income ($16.7) million. Guidance raised.

“announced financial and operating results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights • Total revenue for the first quarter of 2026 was $75.6 million, compared to $96.0 million in the first quarter of 2025. This decline was entirely due to the wind-down of migrant-related programs, which generated zero revenue in the first”
MGX Metagenomi Therapeutics, Inc.

Metagenomi Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2026.

“today reported financial results for the first quarter ended March 31, 2026, and provided business updates.”
MGX Metagenomi Therapeutics, Inc.

Metagenomi Therapeutics, Inc. reported financial results for the quarter ended March 31, 2026.

“On May 11, 2026, Metagenomi Therapeutics, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2026 and additional business updates.”
LAND GLADSTONE LAND Corp

GLADSTONE LAND Corp reported the first quarter ended March 31, 2026 results: net income Net loss for the quarter was approximately $4.3 million, compared to net income of approximately $15.1 million in the pr, EPS $0.24 per share.

“Gladstone Land Corporation (Nasdaq: LAND) (“Gladstone Land” or the “Company”) today reported financial results for the first quarter ended March 31, 2026.”
HIMS Hims & Hers Health, Inc.

Hims & Hers Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $608.1 million, net income $92.1 million. Guidance raised.

“Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results Revenue of approximately $608 million, up 4% year-over-year in Q1 2026”
SANA Sana Biotechnology, Inc.

Sana Biotechnology, Inc. reported financial results for first quarter 2026.

“On May 11, 2026, Sana Biotechnology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026.”
SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc. reported financial results for the three months ended March 31, 2026.

“Silvercrest Asset Management Group Inc. (the "Company") issued a press release announcing certain consolidated financial and operating results for the three months ended March 31, 2026.”
LENZ LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc. reported the first quarter ended March 31, 2026 results: net income Net loss for the three months ended March 31, 2026 was $41.5 million, EPS $1.32 per share (basic and diluted).

“LENZ Therapeutics, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026”
SPG SIMON PROPERTY GROUP INC.

SIMON PROPERTY GROUP INC. reported financial results for the quarter ended March 31, 2026.

“On May 11, 2026, Simon Property Group, Inc. issued a press release containing information on earnings for the quarter ended March 31, 2026 and other matters.”
UEIC UNIVERSAL ELECTRONICS INC

UNIVERSAL ELECTRONICS INC reported the three months ended March 31, 2026 results: revenue $79.0 million, net income $7.3 million, EPS $0.58 per share.

“GAAP net sales were $79.0 million, compared to $92.3 million.”
GTM ZoomInfo Technologies Inc.

ZoomInfo Technologies Inc. reported the first quarter ended March 31, 2026 results: revenue $310.2 million, EPS $0.10.

“while at the same time structuring our business around how customers leverage that data, wherever GTM work happens.” First Quarter 2026 Financial Highlights: • GAAP Revenue of $310.2 million, an increase of 1.5% year-over-year. • GAAP Operating income of $57.9 million and Adjusted operating income of $109.7 million. • GAAP Operating income margin of 19% and Adjusted”
REKR Rekor Systems, Inc.

Rekor Systems, Inc. reported financial results for first quarter ended March 31, 2026.

“On May 11, 2026, Rekor Systems, Inc. (the “Company”) issued a press release summarizing the Company’s financial results for the first quarter and the fiscal year ending December 31, 2026.”
PLRX PLIANT THERAPEUTICS, INC.

PLIANT THERAPEUTICS, INC. reported first quarter ended March 31, 2026 results: net income Net loss was $20.0 million.

“On May 11, 2026, Pliant Therapeutics, Inc. (the "Company") issued a press release announcing the Company’s financial results for the first quarter ended March 31, 2026.”
KLTR KALTURA INC

KALTURA INC reported first quarter ended March 31, 2026 results: revenue Total revenue for the first quarter was $44.6 million, net income GAAP Net loss was $3.8 million, EPS $0.03 per diluted share.

“presentation for the quarter, which now showcases its agentic avatar technology, is available at: https://q1-26-avatar.kaltura.com/ Total revenue for the first quarter was $44.6 million, with subscription revenue of $43.2 million. Adjusted EBITDA for the quarter was $5.7 million. All three results were above the high end of their guidance range. Ron Yekutiel,”
HALO HALOZYME THERAPEUTICS, INC.

HALOZYME THERAPEUTICS, INC. updated its first quarter ended March 31, 2026 guidance (reaffirmed).

“On May 11, 2026, Halozyme Therapeutics, Inc. issued a press release to report its financial results for the first quarter ended March 31, 2026.”
AVBP ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc. reported first quarter ended March 31, 2026 results: net income Net loss was $43.3 million and $64.4 million for the three months ended March 31, 2026 and 2025, respectively..

“Net loss was $43.3 million and $64.4 million for the three months ended March 31, 2026 and 2025, respectively.”
RGTI Rigetti Computing, Inc.

Rigetti Computing, Inc. reported first quarter ended March 31, 2026 results: revenue $4.4 million, net income GAAP net income $33.1 million; non-GAAP net loss $14.7 million, EPS GAAP diluted net loss per share $(0.06); non-GAAP diluted net loss per share $(0.04).

“2026 and provided an update on recent business and technology milestones. First Quarter 2026 Financial Highlights ● Total revenues for the three months ended March 31, 2026 were $4.4 million ● Operating loss for the three months ended March 31, 2026 was $26.0 million ● For the three months ended March 31, 2026: GAAP net income $33.1 million; non-GAAP net loss $14.7”
GANX Gain Therapeutics, Inc.

Gain Therapeutics, Inc. reported first quarter ended March 31, 2026 results: EPS $0.13 per share, basic and diluted.

“Net loss for the three months ended March 31, 2026, was $0.13 per share, basic and diluted, compared to $0.16 per share, basic and diluted, for the three months ended March 31, 2025.”
AURA Aura Biosciences, Inc.

Aura Biosciences, Inc. reported the first quarter ended March 31, 2026 results: net income $33.7 million.

“Net loss for the three months ended March 31, 2026, was $33.7 million, compared to $27.5 million for the three months ended March 31, 2025.”
EIKN Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc. reported first quarter 2026 results: net income $83.0 million.

“Net loss attributable to common stockholders was $83.0 million for the first quarter of 2026, as compared to $74.5 million for the prior-year period.”
METC Ramaco Resources, Inc.

Ramaco Resources, Inc. reported the first quarter of 2026 results: net income quarterly net loss of $(18.3) million, EPS Class A diluted EPS of $(0.30). Guidance reaffirmed.

“On May 11, 2026, Ramaco Resources, Inc. (the “Company”) issued a press release reporting its financial and operating results for the first quarter of 2026”
ERAS Erasca, Inc.

Erasca, Inc. reported financial results for the fiscal quarter ended March 31, 2026.

“On May 11, 2026, Erasca, Inc. (the “Company”) announced the Company’s financial results for the three months ended March 31, 2026.”
ENTA ENANTA PHARMACEUTICALS INC

ENANTA PHARMACEUTICALS INC reported fiscal second quarter ended March 31, 2026 results: revenue $17.2 million, net income Net loss ... $13.1 million, EPS loss of $0.45 per diluted common share.

“multiple value-driving milestones over the coming year.” Fiscal Second Quarter Ended March 31, 2026 Financial Results Total revenue for the three months ended March 31, 2026 was $17.2 million and consisted of royalty revenue from worldwide net sales of MAVYRET®/MAVIRET® (glecaprevir/pibrentasvir), AbbVie’s treatment for hepatitis C virus, compared to $14.9 million for”
KYNB KYNTRA BIO, INC.

KYNTRA BIO, INC. reported first quarter 2026 results: revenue $3.7 million, net income $15.1 million, or $3.74 net loss per basic and diluted share, EPS $3.74 net loss per basic and diluted share.

“Total revenue from continuing operations for the first quarter of 2026 was $3.7 million, as compared to $2.7 million for the first quarter of 2025. • Net loss from continuing operations for the first quarter of 2026 was $15.1 million, or $3.74 net loss per basic and diluted share, compared to a net loss of $16.8 million, or $4.15 net loss per basic and diluted share, one year ago.”
SEPN Septerna, Inc.

Septerna, Inc. reported first quarter ended March 31, 2026 results: revenue $26.5 million, net income $8.6 million.

“$522.1 million as of March 31, 2026. Septerna expects its existing cash runway to fund operations at least into 2029. o Revenue: Revenue from the Novo Nordisk collaboration was $26.5 million for the quarter ended March 31, 2026, compared to $0.2 million from Vertex for the quarter ended March 31, 2025. Revenue for the quarter ended March 31, 2026 included the”
MARA MARA Holdings, Inc.

MARA Holdings, Inc. reported preliminary financial results for fiscal quarter ended March 31, 2026.

“On May 11, 2026, MARA Holdings, Inc. (the “Company”) issued a shareholder letter announcing its financial results for the fiscal quarter ended March 31, 2026.”
FLYX FLYEXCLUSIVE INC.

FLYEXCLUSIVE INC. reported financial results for the three months ended March 31, 2026.

“On May 11, 2026, flyExclusive, Inc. (the “Company”) issued a corporate presentation of its financial results for the three months ended March 31, 2026.”
AREN Arena Group Holdings, Inc.

Arena Group Holdings, Inc. reported the three months ending March 31, 2026 results: revenue $20.4 million, net income $2.7 million.

“The Arena Group Reports Q1 2026 Results Monetization Strategy Optimization, Licensing and Commerce Growth, and AI Adoption Efforts Fuel 2026 Momentum NEW YORK – May 11, 2026 – The Arena Group Holdings, Inc. (NYSE American: AREN) (“The Arena Group” or “Arena”), the brand, data and IP company home to many of the nation's most recognizable brands, including Parade, TheStreet, Men’s Journal, Athlon Sports, ShopHQ and the Adventure Network (including Surfer, Powder, Bike Magazine and more), today announced financial results for the three months ending March 31, 2026 (“Q1 2026”). Financial Highlights for Q1 2026: • First quarter revenue was $20.4 million, compared to $31.8 million in Q1 2025, and gross margin was 34.8% in Q1 2026, compared to 49.4% in Q1 2025, reflecting changes in referral traffic patterns between periods alongside the impact of strategic technical testing performed in Q1 2026 to drive yield and accelerate long-term audience growth. • Net loss was $2.7 million, or -13.2% of”
ALCO ALICO, INC.

ALICO, INC. reported the second quarter ended March 31, 2026 results: revenue $5,340, net income $11,381, EPS $1.49.

“except for per share amounts and percentages) (Unaudited) (Unaudited) Three Months Ended March 31, Six Months Ended March 31, 2026 2025 % Change 2026 2025 % Change Revenue $ 5,340 $ 17,980 (70.3) % $ 7,227 $ 34,874 (79.3) % Net income (loss) attributable to Alico, Inc. common stockholders $ 11,381 $ (111,385) 110.2 % $ 7,900 $ (120,552) 106.6 % Gain (loss)”
APEI AMERICAN PUBLIC EDUCATION INC

AMERICAN PUBLIC EDUCATION INC reported the first quarter ended March 31, 2026 results: revenue $174.7 million, net income $17.7 million, EPS $0.94. Guidance raised.

“foundation is built, the strategy is working, and we are just getting started.” Key First Quarter 2026 Highlights (as Compared to First Quarter 2025) · Consolidated revenue of $174.7 million, a 6.2% year-over year increase. o Excluding the effect of the sale of GSUSA in July 2025, consolidated revenue would have increased 8.7% when compared to the prior period. o”
PLUG PLUG POWER INC

PLUG POWER INC reported first quarter ended March 31, 2026 results: revenue $163.5 million, EPS ($0.18).

“Plug’s integrated hydrogen platform, improving unit economics, and continued demand across core markets. Q1 2026 Financial Highlights · Revenue increased 22% year-over-year to $163.5 million, reflecting growth across material handling and electrolyzer businesses · GAAP gross margin improved to (13%) from (55%) in the prior-year period, representing a 71% improvement”
AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd. reported the three-month period ended March 31, 2026 results: revenue $2.8 million, net income $0.4 million, EPS $0.15 per basic and diluted ADS.

“Net revenues for the first quarter of 2026 increased by 21.0% to $2.8 million from $2.3 million for the same period of 2025.”
CNDT CONDUENT Inc

CONDUENT Inc reported first quarter 2026 results: revenue $723M, net income $(33)M, EPS $(0.23). Guidance reaffirmed.

“of that section. --- EX-99.1 (EX-99.1) --- News from Conduent Conduent Reports Significantly Improved First Quarter 2026 Financial Results Key Q1 2026 Highlights • Revenue: $723M, down 3.7%. Growth in Government and Transportation segments • Pre-tax Income (Loss): $(27)M, improved by $29M year-over-year • Adj. EBITDA (1) : $49M, improved by $12M”
NGS NATURAL GAS SERVICES GROUP INC

NATURAL GAS SERVICES GROUP INC reported three months ended March 31, 2026 results: revenue $48.5 million, net income $6.8 million, or $0.53 per diluted share, EPS $0.53 per diluted share. Guidance raised.

“Total revenue for the three months ended March 31, 2026, increased 17.1% to $48.5 million from $41.4 million for the three months ended March 31, 2025.”
LINC LINCOLN EDUCATIONAL SERVICES CORP

LINCOLN EDUCATIONAL SERVICES CORP reported first quarter ended March 31, 2026 results: revenue $144.0 million, net income $4.4 million, or $0.14 per share, EPS $0.14 per share. Guidance raised.

“Quarter 2026 Financial and Operational Highlights (Quarter ended March 31, 2026, compared to quarter ended March 31, 2025, unless otherwise noted) • Revenue increased 22.5% to $144.0 million from $117.5 million • Net income more than doubled to $4.4 million, or $0.14 per share, compared to $1.9 million, or $0.06 per share • Adjusted EBITDA 1 increased 85% to $15.5”
PESI PERMA FIX ENVIRONMENTAL SERVICES INC

PERMA FIX ENVIRONMENTAL SERVICES INC reported first quarter ended March 31, 2026 results: revenue $11.1 million, net income approximately $7.5 million, EPS $0.40 per share.

“performance beginning in the second quarter, through the balance of 2026, and over the longer term as these opportunities continue to scale.” Financial Results Revenue was $11.1 million for the first quarter of 2026, compared to $13.9 million for the corresponding period in 2025. Treatment Segment revenue decreased by approximately $1.3 million to $7.9 million”
MOS MOSAIC CO

MOSAIC CO reported the first quarter of 2026 results: net income a net loss of $258 million, EPS diluted earnings per share (EPS) of $(0.81).

“The Mosaic Company (NYSE: MOS), reported a net loss of $258 million and diluted earnings per share (EPS) of $(0.81) for the first quarter of 2026.”
AISP Airship AI Holdings, Inc.

Airship AI Holdings, Inc. reported first quarter ended March 31, 2026 results: revenue $6.3 million, net income $721,000, or $0.02 per basic share.

“RELEASE) --- EX-99.1 2 airsp_ex991.htm PRESS RELEASE airsp_ex991.htm EXHIBIT 99.1 Airship AI Reports First Quarter 2026 Financial Results First Quarter 2026 Net Revenues of $6.3 Million, Gross Profit of $3.2 Million and Gross Margin of 50% Net Revenue Increase of 15% and Gross Margin Increase of 42% as Compared to Q1 of the Prior Year Redmond, WA – May 11 , 2026”
TLS TELOS CORP

TELOS CORP reported first quarter ended March 31, 2026 results: revenue $47.7 million, net income $2.0 million. Guidance reaffirmed.

“Telos Corporation Reports 56% Revenue Growth and Continued Strong Profitability and Cash Flow Margins; Reaffirms Full Year Outlook • Substantial Growth : Revenue grew 56% year-over-year to $47.7 million, exceeding guidance, and driven by 78% growth in Security Solutions primarily due to the expansion of large programs in Telos ID. • Healthy Gross Margins : GAAP Gross Margin and Cash Gross Margin 1 both exceeded guidance assumptions primarily due to performance in Telos ID. GAAP Gross Margin was 36.4% and Cash Gross Margin 1 was 42.3%. • Rigorous Expense Discipline : GAAP Operating Expenses decreased 25% year-over-year primarily due to lower stock-based compensation expense. Adjusted Operating Expenses 1 decreased 8% primarily due to restructuring and cost management initiatives. • Expanding Operating Margins : GAAP Net Income was $2.0 million.”
ADIL ADIAL PHARMACEUTICALS, INC.

ADIAL PHARMACEUTICALS, INC. reported first quarter ended March 31, 2026 results: net income $2.0 million.

“Net Loss was $2.0 million for the three months ended March 31, 2026, compared to a net loss of $2.2 million for the three months ended March 31, 2025.”
DRCT Direct Digital Holdings, Inc.

Direct Digital Holdings, Inc. reported three months ended March 31, 2026 results: revenue $6.7 million, net income Net loss was $5.6 million.

“• Revenue of $6.7 million decreased 18% compared to $8.2 million in the first quarter of 2025. The decrease in revenue was driven primarily by a $2.0 million decrease in spending by demand side platform (“DSP”) customers during the first quarter of 2026. • Gross profit was $2.3 million, or 34% of revenue, compared to $2.4 million, or 29% of revenue, in the first quarter of 2025. • Operating expenses of $5.5 million decreased 13% compared to $6.3 million in the first quarter of 2025. • Operating loss was $3.3 million, compared to $3.9 million in the first quarter of 2025. • Net loss was $5.6 million compared to net loss of $5.9 million in the first quarter of 2025.”
UG UNITED GUARDIAN INC

UNITED GUARDIAN INC reported the first quarter of 2026 results: revenue $2,872,222, net income $818,902, EPS $0.18 per share.

“announced today the financial results for the first quarter of 2026. First quarter sales increased from $2,481,127 in 2025 to $2,872,222 in 2026, with net income increasing from $560,895 ($0.12 per share) to $818,902 ($0.18 per share).”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.